OKYO Pharma (NASDAQ:OKYO – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a research note issued on Thursday, Benzinga reports. They currently have a $7.00 target price on the stock. HC Wainwright’s target price would suggest a potential upside of 469.11% from the company’s previous close. HC Wainwright also issued estimates for OKYO Pharma’s Q2 2025 earnings at ($0.11) EPS, Q4 2025 earnings at ($0.09) EPS and FY2025 earnings at ($0.40) EPS.
OKYO Pharma Stock Performance
OKYO Pharma stock opened at $1.23 on Thursday. OKYO Pharma has a 12 month low of $0.81 and a 12 month high of $2.12. The stock’s 50-day moving average is $1.04 and its 200-day moving average is $1.24.
OKYO Pharma Company Profile
Recommended Stories
- Five stocks we like better than OKYO Pharma
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 Undervalued Technology Stocks With Big Rebound Potential
- Trading Halts Explained
- NextEra Energy’s Strong Quarter Catches Wall Street’s Eye
- 3 Tickers Leading a Meme Stock Revival
- Goldman’s Lost Decade Forecast: These 3 Growth Stocks Can Win
Receive News & Ratings for OKYO Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OKYO Pharma and related companies with MarketBeat.com's FREE daily email newsletter.